Chrisann Kyi

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 18 papers. Top paper: “Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses”.

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies

JAMA Oncology(2025)10.1001/jamaoncol.2024.5364

N/A

0.292DataRank · unranked

6 citations

Monica F. Chen, Anne Marie Noronha, Kristalla Panageas, Maggie Reynolds, Kaelyn Kohlasch +22 more

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026

N/A

0.269DataRank · unranked

5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03529-w

N/A

0DataRank · unranked

36 citations

Jeremy Meyerberg, Leila Peraro, Tatyana Korontsvit, Thomas J. Gardner, Manish Malviya +6 more

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Advances in Oncology(2023)10.1016/j.yao.2023.01.004

N/A

0DataRank · unranked

1 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

Research Square(2023)10.21203/rs.3.rs-2887299/v1

N/A

0DataRank · unranked

4 citations

Leila Peraro, Jeremy Meyerberg, Tatyana Korontsvit, Manish Malviya, Thomas J. Gardner +6 more

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100831

N/A

0DataRank · unranked

9 citations

Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu‐Rustum, Carol Aghajanian, Vance Broach +14 more

Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100852

N/A

0DataRank · unranked

36 citations

Claire F. Friedman, Jennifer J. Mueller, Ryma Benayed, Marc Ladanyi, Maria E. Arcila +4 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005

N/A

0DataRank · unranked

3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.021

N/A

0DataRank · unranked

2 citations

M. Herman Chui, Pier Selenica, Kara Long Roche, Yukio Sonoda, Rachel N. Grisham +6 more

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Hematology/Oncology Clinics of North America(2025)10.1016/j.hoc.2025.04.015

N/A

0DataRank · unranked

0 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.003

N/A

0DataRank · unranked

48 citations

Dib Sassine, Alli Straubhar, Aaron Praiss, Carol Aghajanian, Kaled M. Alektiar +17 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more